Immunomodulatory agents have gained widespread use in the treatment of several disorders and so have the complications associated with their use. This is the first case to our knowledge in a pregnant woman with Crohn’s disease and history of treatment with both agents who was diagnosed with a T-cell acute lymphoblastic lymphoma.

Authors: Adeola Awomolo, Theofano Orfanelli, Joshua Segal, Christina Duzyj

Key Words: Lymphoma, pregnancy, Crohn’s disease, immunomodulators